longevitywatch
← All podcasts

Huberman Lab

hosted by Andrew Huberman

We tested 76 claims from Huberman Lab against the research. 12 held up, 13 did not, and the rest are partly true or still too early to judge.

Andrew Huberman: who he is, what he sells, where he stands →

What a speaker claims elsewhere is on their own profile.

We only test the claims that can be checked, not everything that is said. This is not a ranking.

Paul Stamets

American mycologist, author and researcher in medicinal applications of mushrooms

✗ Does not hold up
“Depression causes an inflammatory state in the body that suppresses the immune system, while feeling happier actually activates it”
Paul Stamets (American mycologist, author and researcher in medicinal applications of mushrooms) · Huberman Lab, November 2026 · watch the episode ↗︎ · stated with confidence
The claim reverses the actual relationship: it is chronic stress that demonstrably suppresses the immune system, largely through the stress hormone cortisol. The idea that depression itself causes an inflammatory state that suppresses the immune system is not supported by the available research in that way. The second part of the claim, that feeling happier activates the immune system, has not been demonstrated in research as a symmetrical mechanism; what has been shown is that short-term stress temporarily mobilises the immune system, but that concerns stress, not positive mood. The claim combines two half-truths into an overly neat, reversible story that the evidence does not support.
Too early
“Reishi mushrooms can improve sleep quality.”
Paul Stamets (American mycologist, author and researcher in medicinal applications of mushrooms) · Huberman Lab, November 2026 · watch the episode ↗︎ · stated with caution
Laboratory and animal research into reishi is promising enough to take seriously, but convincing evidence in humans is lacking. The available studies in humans are scarce and weak, and that applies specifically to sleep quality as an outcome measure as well. Early trials in humans are underway, but they have not yet yielded published results, so whether reishi actually improves sleep cannot be said at this point.
Partly
“Psilocybin increases the neuroplasticity of the brain and stimulates the formation of new neural networks.”
Paul Stamets (American mycologist, author and researcher in medicinal applications of mushrooms) · Huberman Lab, November 2026 · watch the episode ↗︎ · stated with confidence
Psilocybin does indeed stimulate the formation of new connections between brain cells and temporarily makes mental patterns more flexible, which is consistent with the idea of increased neuroplasticity. However, the claim goes beyond the available evidence: the studies are still small, often lack a proper control group, and whether this actually leads to lasting new neural networks in humans has not yet been demonstrated. Ongoing early-phase clinical trials are currently investigating this, but results have not yet been published.
Partly
“Acupuncture at specific pressure points can release certain signalling molecules and influence inflammation”
Paul Stamets (American mycologist, author and researcher in medicinal applications of mushrooms) · Huberman Lab, November 2026 · watch the episode ↗︎ · stated with caution
Research shows that acupuncture at specific points does indeed release substances such as pain-relieving and anti-inflammatory compounds, and that this can influence inflammatory processes. Several review studies describe this mechanism in detail, but a large part of the evidence comes from animal and laboratory research. The review study on acupuncture point ST36, a widely used acupuncture point on the lower leg, is even based entirely on animal research. A study in which the substance adenosine was released during acupuncture was conducted in mice. The review studies in humans conclude that large randomised controlled trials demonstrating the direct and lasting effect in humans are still lacking. The claim is therefore correct in its direction, but broader than what the evidence in humans firmly supports so far.
Partly
“Treatment with psilocybin leads to recovery from treatment-resistant depression in 40 to 45 percent of patients”
Paul Stamets (American mycologist, author and researcher in medicinal applications of mushrooms) · Huberman Lab, November 2026 · watch the episode ↗︎ · stated with caution
Psilocybin shows positive signs in people with depression, but the studies are still small and usually lack a proper control group. It is plausible that the direction is correct; however, that exactly 40 to 45 percent of patients recover cannot be substantiated on the basis of current research. Most trials are still in phase 2 and only a handful have published results, which means it is too early to cite definitive recovery rates.
Partly
“Microdosing with psilocybin is associated in observational research with improved mood and a reduction in depression and anxiety.”
Paul Stamets (American mycologist, author and researcher in medicinal applications of mushrooms) · Huberman Lab, November 2026 · watch the episode ↗︎ · stated with confidence
Observational research into psilocybin microdosing does show positive signals for mood, depression and anxiety, but the studies are small and generally lack a proper control group. This makes it difficult to determine whether psilocybin itself is responsible for the improvements or whether other factors are at play. The claim presents the association as a fairly solid finding, whereas the evidence is still limited and long-term effects have not been well mapped out. Controlled trials in humans are still at an early stage, so whether this pattern holds up outside observational settings has yet to be demonstrated.
Partly
“Mycelium grown on rice stimulates the production of the anti-inflammatory cytokines interleukin-10 and interleukin-1RA.”
Paul Stamets (American mycologist, author and researcher in medicinal applications of mushrooms) · Huberman Lab, November 2026 · watch the episode ↗︎ · stated with confidence
One laboratory study using human blood cells (published in a scientific journal with article number 31791317) examined the root network of the fungus Trametes versicolor, grown on rice flour, and found elevated levels of IL-10 and IL-1RA: substances that can suppress inflammation in the body. This result partially supports the claim. However, the rise in these anti-inflammatory substances was found mainly in the fermented rice on which the root network had grown, not or barely in the root network itself. The claim attributes the effect to the root network, whereas the study suggests that the processed rice substrate plays a greater role. Furthermore, this is a single laboratory study, not a study in which people actually consumed the product.
Partly
“Non-psychedelic mushrooms can increase brain substances such as BDNF, which contributes to the brain's ability to adapt and learn.”
Paul Stamets (American mycologist, author and researcher in medicinal applications of mushrooms) · Huberman Lab, November 2026 · watch the episode ↗︎ · stated with caution
Research into the lion's mane mushroom (Hericium erinaceus) shows that it contains compounds that can stimulate the production of growth factors for nerve cells, including two specific proteins that help nerve cells grow and survive. Most of these findings come from laboratory and animal studies; studies involving actual humans are still limited in number and size. The claim refers to "non-psychedelic mushrooms" in general, whereas the research focuses almost exclusively on one specific species. Moreover, the claim mentions one particular protein as an example, while most of the evidence in these studies concerns a different protein; for that first protein, indications have been found in a review study, but the evidence from human studies remains very limited.

Dr. Susanna Søberg

Danish researcher and author in cold and heat therapy and metabolism

Partly
“Activating brown fat can help reduce the amount of white fat in the body.”
Dr. Susanna Søberg (Danish researcher and author in cold and heat therapy and metabolism) · Huberman Lab, November 2026 · watch the episode ↗︎ · stated with caution
Brown fat burns energy as heat and is therefore fundamentally different from white fat, which is well established. That activating brown fat consumes energy is correct, but whether this also leads to a measurable reduction of white fat in humans is another question. Research shows that cold exposure can activate brown fat in humans, but the step towards an actual decrease in white fat has not yet been demonstrated. The claim therefore goes beyond the available evidence.
Partly
“Activated brown fat absorbs glucose and fatty acids from the bloodstream to produce body heat”
Dr. Susanna Søberg (Danish researcher and author in cold and heat therapy and metabolism) · Huberman Lab, November 2026 · watch the episode ↗︎ · stated with confidence
Brown fat does indeed burn energy as heat, and the fact that it absorbs substances from the bloodstream to do so is consistent with the mechanism described in the research. The claim about glucose and fatty acids as fuel is biologically plausible and consistent with what is known about brown fat activation. What the available research does not confirm, however, is that both fuels are absorbed in equal measure: the evidence focuses primarily on activation itself through cold, not on the precise ratio of glucose to fatty acid uptake in practice in humans.
Partly
“Wearing a cooling vest for ten days stimulates the growth of brown adipose tissue”
Dr. Susanna Søberg (Danish researcher and author in cold and heat therapy and metabolism) · Huberman Lab, November 2026 · watch the episode ↗︎ · stated with confidence
Cold exposure can activate brown fat, and there are indications that repeated exposure can also increase the amount of brown fat. However, the specific claim, wearing a cooling vest for ten days as a method to stimulate brown fat growth, goes beyond what the research has firmly established so far. Cold exposure has the strongest support as an activator of brown fat; whether a cooling vest provides the right intensity and duration for that purpose, and whether "growth" actually occurs within that timeframe, has not been demonstrated.
Partly
“Exposure to cold activates brown adipose tissue, which boosts metabolism”
Dr. Susanna Søberg (Danish researcher and author in cold and heat therapy and metabolism) · Huberman Lab, November 2026 · watch the episode ↗︎ · stated with confidence
That cold exposure activates brown adipose tissue is well established: clinical research shows that this substantially boosts metabolism during exposure through heat production. The claim therefore holds for that moment. However, whether that activation translates into a persistently higher metabolism outside of cold exposure has not yet been demonstrated in humans. The claim gives the impression that the effect is structural, and that goes beyond what the research has shown so far.
Partly
“Spending a total of 11 minutes in cold water and 57 minutes in the sauna per week stimulates cell repair through heat shock proteins.”
Dr. Susanna Søberg (Danish researcher and author in cold and heat therapy and metabolism) · Huberman Lab, November 2026 · watch the episode ↗︎ · stated with caution
Heat does indeed trigger a repair response in cells: with repeated exposure, cells produce repair proteins and become more resilient, which is supported by multiple reviews. However, the specific figures of 11 minutes of cold water and 57 minutes of sauna per week cannot be found in research identifying those thresholds as optimal. Moreover, it is the sauna that involves heat shock proteins, while cold water activates a different mechanism; the claim conflates the two as though they have the same effect. The direction is correct, then, but those precise doses cannot be substantiated.
Partly
“Winter swimmers process and remove glucose from their bloodstream more quickly after ingestion than non-winter swimmers.”
Dr. Susanna Søberg (Danish researcher and author in cold and heat therapy and metabolism) · Huberman Lab, November 2026 · watch the episode ↗︎ · stated with confidence
One small study shows a better insulin response in women who swim in cold water, which is consistent with the direction of the claim. However, that finding has not been confirmed in larger or well-controlled studies, and it specifically concerns insulin response in women, not glucose processing and removal in winter swimmers in general. The claim is broader and more assertive than the available evidence justifies.
Partly
“Sleeping for a month at a room temperature of 19 degrees Celsius activates brown fat, increases the amount of brown fat and improves insulin sensitivity.”
Dr. Susanna Søberg (Danish researcher and author in cold and heat therapy and metabolism) · Huberman Lab, November 2026 · watch the episode ↗︎ · stated with confidence
Cold exposure is indeed the best-supported way to activate brown fat in humans, and the possibility that it can also increase the amount of brown fat is consistent with what research shows. The link with improved insulin sensitivity via brown fat is biologically plausible, but whether a room temperature of exactly 19 degrees Celsius for one month produces all three effects simultaneously goes beyond what the available evidence firmly establishes. The claim points in the right direction, but the specificity of that temperature and the combination of all three outcomes as a package cannot be substantiated.
Partly
“Four to five months of regular winter swimming lowers blood pressure and heart rate and improves insulin sensitivity in middle-aged people.”
Dr. Susanna Søberg (Danish researcher and author in cold and heat therapy and metabolism) · Huberman Lab, November 2026 · watch the episode ↗︎ · stated with confidence
Small studies show positive signals for winter swimming, including improved insulin response, but none of these findings have been confirmed in large or well-controlled trials. The claim is therefore more specific than the research allows: the alleged effects on blood pressure and heart rate in middle-aged people have not yet been firmly established for regular cold-water swimming, and there is also evidence that sharp rises in blood pressure are a risk. The direction of the claim is plausible for some outcomes, but the certainty and completeness it implies go beyond what the available evidence supports.

Dr. Scott Kanoski

Professor of Human and Evolutionary Biology and Neurobiology at the University of Southern California

Partly
“Nausea and vomiting are the most common side effects of GLP-1 medications and cause many people to discontinue treatment.”
Dr. Scott Kanoski (Professor of Human and Evolutionary Biology and Neurobiology at the University of Southern California) · Huberman Lab, October 2026 · watch the episode ↗︎ · stated with confidence
Several review studies in humans confirm that gastrointestinal complaints, particularly nausea, vomiting, diarrhoea and constipation, are the most common side effects of GLP-1 medications, and that they can affect treatment adherence. The claim is therefore correct with regard to the type of side effects. However, the assertion that many people discontinue treatment as a result goes beyond what the studies consistently show: the complaints are generally described as mild to moderate, occur mainly when the dose is increased and often diminish thereafter. Moreover, nausea and vomiting together are the most frequently mentioned complaints, but in the studies they are often listed alongside diarrhoea and constipation without vomiting being specifically highlighted as the second most important. The extent to which discontinuation results from these side effects varies by drug and is not equally well substantiated in all studies. → Do GLP-1 medications cause suicidal thoughts?
✓ Holds up
“A few hours after a meal, hunger is more strongly determined by the memory of what a person saw than by the amount actually eaten”
Dr. Scott Kanoski (Professor of Human and Evolutionary Biology and Neurobiology at the University of Southern California) · Huberman Lab, October 2026 · watch the episode ↗︎ · stated with confidence
Research in humans shows that immediately after a meal, hunger is determined primarily by the amount actually eaten, but two to three hours later this reverses: at that point, the memory of what you thought you had eaten is the strongest predictor of how hungry you feel. This has been demonstrated, among other things, in an experiment in which participants received more or less soup than they saw via a hidden pump, so that the volume seen and the volume consumed could be varied independently of each other. Several studies in humans confirm that meal memories play an independent role in regulating appetite and subsequent intake. The claim closely matches what this research shows.
✓ Holds up
“People who are reminded of their recent lunch eat less during a subsequent snack test”
Dr. Scott Kanoski (Professor of Human and Evolutionary Biology and Neurobiology at the University of Southern California) · Huberman Lab, October 2026 · watch the episode ↗︎ · stated with confidence
Research in humans shows that participants who were asked to think about what they had eaten earlier that day subsequently ate less during a snack test than people who were not reminded of this. This effect was found in women without dietary restrictions and proved to be specific to the lunch of that same day: being reminded of the previous day's lunch had no effect on snack intake. Several review articles confirm that this so-called meal-memory effect is a robust phenomenon in healthy adults. One study adds that the effect also occurs when people imagine their lunch as larger than it actually was, but that thinking back to the meal in detail does not strengthen the effect.
Partly
“If the sensory vagus nerve from the gastrointestinal tract is damaged, the body's own GLP-1 no longer reduces food intake in animals”
Dr. Scott Kanoski (Professor of Human and Evolutionary Biology and Neurobiology at the University of Southern California) · Huberman Lab, October 2026 · watch the episode ↗︎ · stated with confidence
Animal research shows that the sensory fibres of the vagus nerve from the gastrointestinal tract play an important role in transmitting the satiety signal of the body's own GLP-1. Studies in rodents show that disabling or damaging these vagal nerve pathways strongly reduces or abolishes the appetite-suppressing effect of GLP-1. However, several studies nuance this picture: the reduction in food intake is sometimes only weakened rather than completely absent, and there are indications that other signalling pathways can partially take over. Furthermore, one study shows that the effect of the body's own GLP-1 partly depends on the simultaneous presence of other gut hormones, which means the claim is formulated somewhat too absolutely.
Partly
“Both GLP-1 in the gut and GLP-1 in the brain suppress hunger, but the two systems appear to operate independently of each other”
Dr. Scott Kanoski (Professor of Human and Evolutionary Biology and Neurobiology at the University of Southern California) · Huberman Lab, October 2026 · watch the episode ↗︎ · stated with caution
GLP-1 demonstrably suppresses hunger via both the gut and the brain: it slows gastric emptying and influences brain regions that regulate satiety. The claim that both systems operate independently of each other goes beyond what the available research shows. That independence has not been demonstrated in the sources currently available.
Partly
“A junk food diet causes memory problems in rodents that persist after they switch to a healthy diet”
Dr. Scott Kanoski (Professor of Human and Evolutionary Biology and Neurobiology at the University of Southern California) · Huberman Lab, October 2026 · watch the episode ↗︎ · stated with confidence
Research in rats and mice does indeed show that a junk food or Western diet causes memory problems. One study in female rats found that memory problems persisted after switching to a healthy diet, but a study in mice found that memory problems and brain metabolism problems fully resolved after eight weeks of normal eating. The findings are therefore partly contradictory: whether the damage persists or resolves appears to depend on factors such as species, sex, age, and the precise composition and duration of the diet. The claim that memory problems always persist after returning to a healthy diet is therefore too categorical given the available animal research.

Dr. Ralph Adolphs

professor of psychology, neuroscience and biology at Caltech

✓ Holds up
“Structured breathing exercises can increase heart rate variability (HRV).”
Dr. Ralph Adolphs (professor of psychology, neuroscience and biology at Caltech) · Huberman Lab, August 2026 · watch the episode ↗︎ · repeated in September 2026 · stated with confidence
Correct: slow, structured breathing (around six breaths per minute) demonstrably increases heart rate variability, at least during and directly after the exercise.
Too early
“Nattokinase as a supplement may help lower LDL cholesterol levels.”
Dr. Ralph Adolphs (professor of psychology, neuroscience and biology at Caltech) · Huberman Lab, August 2026 · watch the episode ↗︎ · stated with confidence
There are small studies showing a reduction in LDL cholesterol, but large and replicated evidence is lacking and quality is variable. It is not a proven cholesterol-lowering agent.
Partly
“Walnuts contain fatty acids that are beneficial for neurons in the brain.”
Dr. Ralph Adolphs (professor of psychology, neuroscience and biology at Caltech) · Huberman Lab, August 2026 · watch the episode ↗︎ · stated with caution
Walnuts are rich in the plant-based omega-3 fatty acid ALA, but the body converts that only to a limited extent into the fatty acids brain cells actually need. Direct evidence for a brain benefit is modest. → How much omega-3 with EPA and DHA do you need per day?
Too early
“Cold therapy, such as ice baths, can increase the resilience of the nervous system against later stressors.”
Dr. Ralph Adolphs (professor of psychology, neuroscience and biology at Caltech) · Huberman Lab, August 2026 · watch the episode ↗︎ · stated with caution
The idea that cold training also makes you more resilient to other stressors (cross-adaptation) is plausible and being researched, but solid evidence in humans is still very limited. → Does cold showering boost your immune system?
✓ Holds up
“Cold water, such as an ice bath, reliably raises adrenaline and noradrenaline levels and may lower cortisol.”
Dr. Ralph Adolphs (professor of psychology, neuroscience and biology at Caltech) · Huberman Lab, August 2026 · watch the episode ↗︎ · stated with confidence
Well documented: immersion in cold water substantially increases the release of adrenaline and especially noradrenaline. That is precisely why an ice bath is so invigorating. → Does cold showering or an ice bath speed up your metabolism?
Partly
“An ice bath can directly and automatically reduce the autonomic emotional response to sudden stress.”
Dr. Ralph Adolphs (professor of psychology, neuroscience and biology at Caltech) · Huberman Lab, August 2026 · watch the episode ↗︎ · shared as personal experience
Cold water demonstrably activates the stress system, and that response diminishes with repeated exposure. But whether an ice bath directly dampens the emotional response to psychological stress has barely been studied directly.

Dr. Abud Bakri

Physician in internal medicine with expertise in peptides

✓ Holds up
“Cardarine showed signs of carcinogenicity in animal studies, which led to the discontinuation of its further development.”
Dr. Abud Bakri (Physician in internal medicine with expertise in peptides) · Huberman Lab, June 2026 · watch the episode ↗︎ · stated with confidence
A review study describes that GW501516 (Cardarine) was discontinued by the pharmaceutical company GSK after earlier research in rodents demonstrated a link with the widespread development of tumours. This occurred after the drug had already been successfully tested in humans. Multiple studies also confirm that GW501516 promotes the growth and spread of colon cancer in mice. The claim that animal studies showed signs of cancer and that this led to the discontinuation of the drug's development is therefore supported by the research.
Too early
“Cardarine (GW501516) increases cardiovascular endurance.”
Dr. Abud Bakri (Physician in internal medicine with expertise in peptides) · Huberman Lab, June 2026 · watch the episode ↗︎ · stated with confidence
Several animal studies show that GW501516 (Cardarine) increases running endurance in mice, including in combination with exercise or in mice with heart failure. This effect is attributed to changes in muscle metabolism, such as a shift towards fat burning. However, all available research has been conducted in mice, and this effect has not yet been tested in humans. The claim implies an effect in humans, while the evidence comes exclusively from animal studies.
✗ Does not hold up
“Rectal administration of BPC-157 showed a positive therapeutic effect in a small phase 2 study on ulcerative colitis.”
Dr. Abud Bakri (Physician in internal medicine with expertise in peptides) · Huberman Lab, June 2026 · watch the episode ↗︎ · stated with caution
Research into BPC-157 in humans is still in its infancy. What is available is limited to a small case series and a pilot study with two participants, and none of those studies has produced results that have been widely confirmed. A positive therapeutic effect in a phase 2 study on ulcerative colitis cannot be substantiated on the basis of the available evidence, and no registered trials with published results exist. The claim therefore goes beyond what the research supports to date.
Partly
“BPC-157 reduces alcohol withdrawal symptoms in animal studies.”
Dr. Abud Bakri (Physician in internal medicine with expertise in peptides) · Huberman Lab, June 2026 · watch the episode ↗︎ · stated with confidence
Animal research on BPC-157 consistently shows positive results, but the available knowledge about this peptide focuses primarily on tissue healing, not specifically on alcohol withdrawal symptoms. Whether BPC-157 reduces those symptoms in animal studies has therefore been neither confirmed nor refuted on the basis of what has been investigated. In humans, BPC-157 has barely been tested at all, and no clinical trials have been registered for the combination with alcohol withdrawal in people. The claim goes beyond what the available evidence on this peptide supports.
✗ Does not hold up
“Combining a GLP-1 agonist, growth hormone or GHRH, and androgen therapy leads to significant fat loss and muscle gain in the short term.”
Dr. Abud Bakri (Physician in internal medicine with expertise in peptides) · Huberman Lab, June 2026 · watch the episode ↗︎ · stated with caution
What we know about GLP-1 agonists actually points in the opposite direction: in people who lose weight with them, roughly a quarter of the weight lost consists of muscle and other lean tissue. Simultaneous muscle gain does not occur. As for growth hormone or GHRH in combination with androgen therapy, the available research contains nothing to suggest that this triple combination has a "significant" short-term effect on both fat and muscle at the same time. Moreover, growth hormone supplementation in healthy older adults yields barely any functional benefit and carries real risks, including an increased risk of cancer.

Dr. Chris Thompson

Professor of Medicine at Harvard Medical School and chief of interventional gastroenterology at Mass General Brigham

✗ Does not hold up
“Overfeeding and obesity lead to elongation of the intestinal villi and an eightfold increase in natural killer cells in the intestinal wall.”
Dr. Chris Thompson (Professor of Medicine at Harvard Medical School and chief of interventional gastroenterology at Mass General Brigham) · Huberman Lab, September 2026 · watch the episode ↗︎ · stated with confidence
Research in mice and rats does show that a high-fat diet or overfeeding affects intestinal structure, but the direction of the effect varies across studies and models. In mice fed large amounts of fructose, villus length increased, but in zebrafish on a high-fat diet, villus length actually decreased. An "eightfold increase" in natural killer cells in the intestinal wall in obesity does not appear in any of the available research: one mouse study on oesophageal tissue even finds a decrease in the proportion of natural killer cells on a high-fat diet. The specific figures and the combination of effects stated in the claim cannot therefore be found in the research, and in some respects the opposite is found.
✓ Holds up
“Oral intake of glucose leads to a significantly higher insulin release than the same amount of glucose administered intravenously.”
Dr. Chris Thompson (Professor of Medicine at Harvard Medical School and chief of interventional gastroenterology at Mass General Brigham) · Huberman Lab, September 2026 · watch the episode ↗︎ · stated with confidence
Multiple review studies and clinical trials in humans confirm this phenomenon, which is called the "incretin effect". Oral glucose stimulates the intestines to secrete hormones that prompt the pancreas to produce additional insulin, causing insulin release to be two to three times higher than with intravenous administration of the same amount of glucose. This effect has been established in healthy individuals; in people with type 2 diabetes, the effect is reduced or absent.
Partly
“Insufficient fibre intake causes gut bacteria to break down the intestinal mucus layer and produce less butyrate, which weakens tight junctions.”
Dr. Chris Thompson (Professor of Medicine at Harvard Medical School and chief of interventional gastroenterology at Mass General Brigham) · Huberman Lab, September 2026 · watch the episode ↗︎ · stated with confidence
That dietary fibre feeds beneficial gut bacteria and contributes to the production of short-chain fatty acids such as butyrate, and that a disrupted microbiome can damage the intestinal barrier, is consistent with what research shows. Nevertheless, the claim goes beyond what the available studies can firmly establish: the specific mechanism by which fibre deficiency leads to breakdown of the mucus layer and weakening of tight junctions via reduced butyrate has not been demonstrated as a connected chain in humans. The individual components are biologically plausible and there is evidence for each separate piece, but as a sequential chain of cause and effect this has not yet been confirmed in well-controlled human research.
Partly
“Supplementing with 40 grams of resistant starch per day significantly improves fatty liver and insulin sensitivity.”
Dr. Chris Thompson (Professor of Medicine at Harvard Medical School and chief of interventional gastroenterology at Mass General Brigham) · Huberman Lab, September 2026 · watch the episode ↗︎ · stated with confidence
A randomised trial in people with non-alcoholic fatty liver disease (NAFLD) shows that four months of resistant starch substantially reduces the amount of fat in the liver. A smaller study in people with impaired insulin response does indeed find an improvement in insulin sensitivity after twelve weeks at 40 grams per day, but that same study sees no effect on fat accumulation in the liver or muscles. The claim that both effects occur 'significantly' is therefore not supported across all studies simultaneously: the liver effect and the insulin effect have been demonstrated in different studies and not always in the same group or at the same dose. Moreover, the larger fatty liver study notes that part of the effect is linked to weight loss, something the claim does not mention. → How dangerous is a fatty liver (hepatic steatosis)?
Partly
“Eating fermented foods increases the diversity of the gut microbiome and lowers inflammatory markers.”
Dr. Chris Thompson (Professor of Medicine at Harvard Medical School and chief of interventional gastroenterology at Mass General Brigham) · Huberman Lab, September 2026 · watch the episode ↗︎ · repeated in November 2026 · stated with confidence
The direction of the claim is correct: fermented foods demonstrably increase the diversity of the gut flora and lower inflammatory markers. However, that evidence comes primarily from small studies and certainly does not apply to every fermented product. Yoghurt and kefir have the strongest support, while products such as kimchi and kombucha have not yet been shown in humans to produce the same effect. The claim gives the impression that this is established for fermented foods in general, which goes beyond what the research currently shows.

Andy Galpin

Professor of kinesiology at California State University, Fullerton and expert in muscle physiology and strength training

Partly
“Acute heavy exercise in the 24 to 48 hours before a body measurement significantly affects the results of a body composition test due to inflammation and fluid retention.”
Andy Galpin (Professor of kinesiology at California State University, Fullerton and expert in muscle physiology and strength training) · Huberman Lab, September 2026 · watch the episode ↗︎ · stated with confidence
Research on ultra-endurance athletes shows that extreme exercise, such as a marathon, ultramarathon or multi-day triathlon, produces measurable changes in fluid balance and body composition immediately afterwards. The marathon and ultramarathon studies found that body weight dropped but partially recovered within 24 hours, partly due to fluid retention and glycogen storage, while the triathlon study showed large increases in inflammatory markers and hormones that were associated with fluid changes. These findings support the principle that heavy exercise can affect measurements. However, all these studies involve extremely prolonged exercise, not ordinary heavy training, and they measure immediately after the event or 24 hours later, not specifically in the window of 24 to 48 hours before a measurement. Whether inflammation and fluid retention are the decisive factors with more everyday heavy exercise, and whether the effect is then "significant", is not clear from the available research.
Partly
“A healthy man should have a grip strength of at least 40 kg on a hand dynamometer, and a healthy woman at least 35 kg.”
Andy Galpin (Professor of kinesiology at California State University, Fullerton and expert in muscle physiology and strength training) · Huberman Lab, September 2026 · watch the episode ↗︎ · stated with confidence
A large international study combining many earlier studies, with data from more than 2.4 million adults in 69 countries, shows that average grip strength varies considerably by age, sex and world region. There is therefore no single international minimum value that applies to all healthy adults. The thresholds of 40 kg for men and 35 kg for women may be recognisable for certain age groups or regions, but the research makes clear that norms always depend on age and sex and vary considerably between groups. The claim suggests one fixed lower limit for all healthy men and women, which goes further than what the research supports.
Partly
“After the age of forty, maximum muscle strength declines by approximately 10% per decade.”
Andy Galpin (Professor of kinesiology at California State University, Fullerton and expert in muscle physiology and strength training) · Huberman Lab, September 2026 · watch the episode ↗︎ · stated with confidence
Muscle strength does indeed decline with age, but the figures in the research point in a different direction than the claim suggests. After the age of fifty, the loss amounts to around 3 to 4% per year, which over a decade is considerably more than the 10% mentioned. Whether that decline already begins at the same rate before the age of fifty cannot be firmly established on the basis of the available research. The direction of the claim is correct, but the percentage per decade that is cited underestimates how quickly the loss can occur.

Dr. Craig Koniver

Physician specialized in performance medicine and peptide treatments

Too early
“BPC-157 upregulates the sensitivity and density of growth hormone receptors.”
Dr. Craig Koniver (Physician specialized in performance medicine and peptide treatments) · Huberman Lab, October 2024 · watch the episode ↗︎ · repeated in June 2026 · stated with confidence
Research shows that BPC-157 increases the presence of growth hormone receptors in tendon tissue cells of rats, and a review of 36 studies confirms this as a known mechanism. However, almost all research has been conducted in animals or in the laboratory; there is only one small retrospective study in humans, which looked at pain complaints rather than growth hormone receptors. Whether BPC-157 also upregulates the density or sensitivity of growth hormone receptors in humans has not yet been tested in humans.
✗ Does not hold up
“The peptide BPC-157 has a strong anti-inflammatory effect and relieves joint and tissue pain.”
Dr. Craig Koniver (Physician specialized in performance medicine and peptide treatments) · Huberman Lab, October 2024 · watch the episode ↗︎ · shared as personal experience
Animal research on BPC-157 is remarkably consistently positive regarding tissue healing and has also yielded indications of anti-inflammatory effects, but that step to humans has not been made. In humans, the evidence consists of a small case series and a pilot study with only two participants, which is insufficient to support a "strong anti-inflammatory effect" or relief of joint and tissue pain. One completed human trial has been registered, but it has not produced any published results. The claim presents as established something that has not yet been demonstrated in humans.
✗ Does not hold up
“When weight loss with GLP-1 agonists through microdosing is limited to a maximum of two pounds (approximately 0.9 kg) per week, no loss of muscle mass occurs.”
Dr. Craig Koniver (Physician specialized in performance medicine and peptide treatments) · Huberman Lab, October 2024 · watch the episode ↗︎ · stated with confidence
Research consistently shows that GLP-1 medications are associated with loss of muscle mass, with roughly a quarter of total weight loss coming from muscle and other non-fat tissue. There is no evidence that a particular rate of weight loss prevents this muscle loss, let alone that a limit of two pounds per week rules it out. The only approach with some supporting evidence for limiting muscle loss is strength training combined with adequate protein intake, not the rate of weight loss.

Jared Diamond

Emeritus professor of geography at UCLA, physiologist and author

✓ Holds up
“Breathing through the mouth is detrimental to the development of facial structure and possibly to health.”
Jared Diamond (Emeritus professor of geography at UCLA, physiologist and author) · Huberman Lab, October 2026 · watch the episode ↗︎ · stated with caution
Multiple studies in children and adolescents show that mouth breathing is associated with measurable changes in facial structure: the jaw tilts backward and downward, the palate is narrower and higher, and the dental arches are narrower. A meta-analysis combining the results of ten individual studies confirms this pattern, as do individual medical studies and a descriptive review article. The airways are also narrower on average in people who breathe through their mouth. Regarding broader health effects, the evidence is less well developed, but the review articles mention associated conditions such as sleep problems and changes in muscle function as additional risks. The claim that mouth breathing is detrimental to the development of facial structure is thus well supported; the part about "possibly to health" is consistent with what the studies describe as accompanying complaints.
Partly
“Exposure to PFAS through drinking water is associated with hormonal disruption, disruption of the gut microbiome, and fertility problems.”
Jared Diamond (Emeritus professor of geography at UCLA, physiologist and author) · Huberman Lab, October 2026 · watch the episode ↗︎ · stated with confidence
Regarding hormonal disruption through drinking water, studies conducted in a heavily contaminated area of Sweden find an increased risk of a hormonal condition in which the ovaries do not function properly (a condition known as polycystic ovary syndrome) in women, but that same study finds no association with a condition in which uterine lining grows outside the uterus. One analysis concludes, on the contrary, that the influence of PFAS in drinking water on hormonal balance is negligibly small compared to other sources. As for gut health, PFAS-induced disruptions of gut bacteria have been demonstrated primarily in mouse studies and in infants exposed to these substances through breast milk, and not directly through drinking water in adults. Furthermore, the Ronneby drinking water study found no convincing evidence that PFAS in drinking water causes inflammatory bowel disease. The claim is partially correct in its direction, but goes further than what research has so far demonstrated for all three of the mentioned effects through drinking water in humans.
✗ Does not hold up
“A nattokinase supplement can help lower LDL cholesterol naturally.”
Jared Diamond (Emeritus professor of geography at UCLA, physiologist and author) · Huberman Lab, October 2026 · watch the episode ↗︎ · stated with caution
The available research on nattokinase shows no demonstrated effect on arterial calcification, blood pressure or coagulation markers after three years of use. There are smaller studies with positive signals, but these are too limited to support firm conclusions, and specific evidence that nattokinase lowers LDL cholesterol has not been established. Anyone taking blood thinners should in any case discuss nattokinase with a doctor first.

Peter Attia

Physician and expert in longevity and healthspan, trained at Stanford University and Johns Hopkins University · Who he is, what he sells, where he stands →

Partly
“To fall into a deep sleep and stay asleep, the body temperature must drop by 1 to 3 degrees, and to wake up feeling alert, it must rise by 1 to 3 degrees.”
Peter Attia (Physician and expert in longevity and healthspan, trained at Stanford University and Johns Hopkins University) · Huberman Lab, July 2024 · watch the episode ↗︎ · repeated in October 2026 · stated with confidence
Research confirms that a drop in body temperature is necessary to fall asleep and stay asleep: if the body is unable to lower its temperature sufficiently, sleep is disrupted. However, the precise range of 1 to 3 degrees for both falling asleep and waking up cannot be found in the available research. The general direction of the claim is correct, but those specific figures cannot be substantiated.
✗ Does not hold up
“As we age, NAD levels in the blood drop by 10 to 20%, while NADH levels rise proportionally.”
Peter Attia (Physician and expert in longevity and healthspan, trained at Stanford University and Johns Hopkins University) · Huberman Lab, July 2024 · watch the episode ↗︎ · stated with confidence
That NAD+ declines with age has been consistently established in humans and animals. However, the claim goes further by stating that the decline amounts to exactly 10 to 20 percent and that NADH rises proportionally: neither of these specific claims is supported by the available research. Furthermore, the decline in NAD+ is related to increased breakdown and reduced production, not necessarily to a proportional rise in NADH.
Partly
“Caloric restriction and rapamycin are the only two interventions that have been convincingly shown to extend lifespan across four different categories of eukaryotes.”
Peter Attia (Physician and expert in longevity and healthspan, trained at Stanford University and Johns Hopkins University) · Huberman Lab, July 2024 · watch the episode ↗︎ · stated with confidence
Both caloric restriction and rapamycin convincingly and repeatedly extend lifespan in animal studies, including across multiple species. However, the claim that this has been 'convincingly demonstrated' across four categories of eukaryotes goes beyond what the available research supports: in humans, a lifespan-extending effect has not yet been proven for either intervention. Moreover, the delineation of exactly four eukaryotic categories is not reflected in the available evidence. The direction of the claim holds for animal models, but the claim is too categorical for the full spectrum.

Dr. Chris Palmer

Psychiatrist and lecturer in psychiatry at Harvard Medical School

Partly
“Fasting and caloric restriction stimulate autophagy and contribute to a longer lifespan through mitochondrial renewal.”
Dr. Chris Palmer (Psychiatrist and lecturer in psychiatry at Harvard Medical School) · Huberman Lab, August 2026 · watch the episode ↗︎ · stated with confidence
It is well established that fasting and eating less activate the cell's cleanup processes, and there are review articles on the subject. The link to a longer lifespan comes from animal research, where caloric restriction extends lifespan in yeasts, worms, flies and rodents. This has not been demonstrated in humans, and the studies that do exist look at intermediate markers rather than actual longevity.
Partly
“The ketogenic diet promotes both mitophagy (the removal of defective mitochondria) and mitochondrial biogenesis.”
Dr. Chris Palmer (Psychiatrist and lecturer in psychiatry at Harvard Medical School) · Huberman Lab, August 2026 · watch the episode ↗︎ · stated with confidence
Both effects have been observed in animal research: the removal of damaged mitochondria and the formation of new ones. This has not been demonstrated in humans, as that would require taking muscle or brain tissue samples before and after. It is a plausible mechanism, but there is no human evidence.
Partly
“The ketogenic diet influences neurotransmitter levels (such as GABA, glutamate and adenosine) and reduces inflammation in the brain.”
Dr. Chris Palmer (Psychiatrist and lecturer in psychiatry at Harvard Medical School) · Huberman Lab, August 2026 · watch the episode ↗︎ · stated with confidence
It has been established that ketones affect the balance between inhibitory and excitatory signalling substances in the brain, and this is the prevailing explanation for why the diet works in epilepsy. The evidence comes almost entirely from animal and laboratory research; in humans, these substances cannot be measured directly in the brain.

Masud Husain

Neurologist and professor of cognitive neuroscience at the University of Oxford

✓ Holds up
“Apathy in old age without prior cognitive impairment doubles the risk of developing Alzheimer's disease.”
Masud Husain (Neurologist and professor of cognitive neuroscience at the University of Oxford) · Huberman Lab, August 2026 · watch the episode ↗︎ · stated with confidence
This association has been found on multiple occasions, including by the speaker himself, who holds a professorship in this field. An important nuance should be added, however: a doubled risk does not mean that apathy causes the disease. It is more likely one of the earliest manifestations of it, appearing years before any visible memory decline. In practice, that distinction matters: apathy is then a signal to take seriously, not a problem you can train away.
✓ Holds up
“Twenty to thirty percent of people with amyloid plaques and tau tangles in the brain show no symptoms of dementia during their lifetime.”
Masud Husain (Neurologist and professor of cognitive neuroscience at the University of Oxford) · Huberman Lab, August 2026 · watch the episode ↗︎ · stated with confidence
Correct, and it is one of the most important findings in Alzheimer's research. Post-mortem examination reveals that a substantial proportion of people who never developed dementia did in fact have protein deposits in their brains. This means that the plaques alone do not explain the disease, and it is the reason why researchers speak of reserve capacity: education, social connections and a healthy vascular system all help determine whether someone with the same brain abnormalities develops symptoms.
✓ Holds up
“Both an overactive and an underactive thyroid can cause measurable cognitive decline and behavioural changes.”
Masud Husain (Neurologist and professor of cognitive neuroscience at the University of Oxford) · Huberman Lab, August 2026 · watch the episode ↗︎ · stated with confidence
Correct, and this is clinically important. An underactive thyroid makes you slow to think, forgetful and low in mood; an overactive one causes restlessness, difficulty concentrating and irritability. Both can be detected with a blood test and are largely reversible with treatment, which is precisely why thyroid testing belongs in the workup for treatable causes of memory complaints.

Dr. Elissa Epel

Professor of Psychiatry at the University of California, San Francisco (UCSF) and stress researcher

Partly
“Short, repeated physical stressors such as high-intensity interval training (HIIT) reduce rumination, depression and anxiety.”
Dr. Elissa Epel (Professor of Psychiatry at the University of California, San Francisco (UCSF) and stress researcher) · Huberman Lab, October 2026 · watch the episode ↗︎ · stated with confidence
Exercise demonstrably reduces low mood and anxiety, and the same applies to rumination. The best-studied forms are walking, jogging and yoga, not specifically HIIT. For anxiety in particular, lighter and shorter sessions tend to work well, which somewhat undermines the emphasis on high intensity as the key factor. The claim is therefore correct in its direction, but presenting HIIT as the decisive factor for these mental health effects cannot be substantiated on the basis of the available research, and in humans this is still being tested in ongoing trials.
Partly
“Experiencing more positive emotions on a daily basis predicts, ten years later, less depression, heart disease and premature death.”
Dr. Elissa Epel (Professor of Psychiatry at the University of California, San Francisco (UCSF) and stress researcher) · Huberman Lab, October 2026 · watch the episode ↗︎ · stated with confidence
The finding that optimism and positive emotions are associated with a lower risk of premature death and cardiovascular mortality has indeed been found in multiple large, long-running studies, and those associations hold up after adjustment for depression and lifestyle. The claim goes beyond the evidence on two points: reduced depression after ten years has not been specifically examined in these studies, and the precise time horizon of ten years is not firmly established. Moreover, these are observational associations, not experimentally demonstrated cause and effect.

Dr. Anna Lembke

Director of the Dual Diagnosis Addiction Clinic and professor of psychiatry at Stanford University School of Medicine

Partly
“GLP-1 agonists may suppress the release of dopamine in the nucleus accumbens in response to addictive substances or high-calorie foods.”
Dr. Anna Lembke (Director of the Dual Diagnosis Addiction Clinic and professor of psychiatry at Stanford University School of Medicine) · Huberman Lab, November 2026 · watch the episode ↗︎ · stated with caution
Animal studies and large analyses of patient data show that GLP-1 agonists can curb the craving for alcohol, nicotine and high-calorie foods, which is consistent with a suppressive effect on the reward system. The nucleus accumbens and dopamine are cited as the likely mechanism, but clinical trials in humans that confirm this specific mechanism are still scarce and yield mixed results. The claim therefore describes a plausible mode of action, but it has not yet been demonstrated that this also occurs in humans via dopamine in the nucleus accumbens.
Partly
“GLP-1 agonists can reduce alcohol cravings in some people with severe alcohol addiction and contribute to recovery.”
Dr. Anna Lembke (Director of the Dual Diagnosis Addiction Clinic and professor of psychiatry at Stanford University School of Medicine) · Huberman Lab, November 2026 · watch the episode ↗︎ · repeated in October 2026 · stated with caution
Animal studies consistently point to reduced alcohol consumption with GLP-1 agonists, and large analyses of patient data show an association in humans with fewer hospital admissions due to alcohol-related problems. The direction of the claim is therefore correct, but clinical trials in humans are scarce and yield mixed results. Furthermore, the evidence is still too limited to say anything specific about people with severe addiction; in humans, this is currently being tested in early-stage trials.

Dr. Gina Poe

Professor of integrative biology and physiology at UCLA, neuroscientist specializing in sleep and memory

Partly
“Keeping consistent bedtimes is an important marker of good neurological health as we age.”
Dr. Gina Poe (Professor of integrative biology and physiology at UCLA, neuroscientist specializing in sleep and memory) · Huberman Lab, September 2026 · watch the episode ↗︎ · stated with confidence
Research in older adults shows that regular rest and activity patterns throughout the day are associated with a lower risk of dementia and better executive functioning. Irregular napping patterns have also been linked to greater Alzheimer's pathology. However, the claim is specifically about consistent bedtimes as a marker of neurological health, whereas the studies take a broader look at day-night rhythms and activity patterns in general, not exclusively at the time a person goes to bed. Moreover, the findings concern associations, not evidence that consistent bedtimes themselves cause better brain health.
Partly
“During deep slow-wave sleep, neurons synchronously contract and expand, flushing waste products and misfolded proteins out of the brain.”
Dr. Gina Poe (Professor of integrative biology and physiology at UCLA, neuroscientist specializing in sleep and memory) · Huberman Lab, September 2026 · watch the episode ↗︎ · stated with confidence
Research confirms that the glymphatic system, the brain's waste-drainage network, is active during sleep and that deep sleep plays the greatest role in this process. The claim that waste products and misfolded proteins are removed in this way is broadly correct. However, the description that neurons synchronously 'contract and expand' to achieve this is a specific mechanistic detail that the available research does not describe in those terms. The cleansing effect of deep sleep has been demonstrated, but the precise cellular mechanism behind this claim cannot be substantiated.

Dr. Andy Galpin

Professor of kinesiology and expert in muscle physiology and strength training

Partly
“People over the age of 90 can achieve a 30% to 170% increase in muscle size and hypertrophy through strength training in 12 weeks.”
Dr. Andy Galpin (Professor of kinesiology and expert in muscle physiology and strength training) · Huberman Lab, September 2026 · watch the episode ↗︎ · stated with confidence
A small 1990 study with nine nonagenarians (average age 90, living in a care facility) showed an average strength gain of 174% after eight weeks of intensive strength training, but muscle size grew by only 9%. The claim mentions an increase in muscle size of 30% to 170%, but in the study that upper figure refers to strength, not muscle size. A review study summarising 22 carefully designed trials in people aged 75 and over confirms that strength training does lead to measurable muscle growth and strength gains, but reports no percentages matching the stated range of 30% to 170% for muscle growth. The claim is therefore correct in its direction (strength training works even at an advanced age), but the specific figures for muscle size are wrong: the large percentage jump applies to strength, not muscle size.
✗ Does not hold up
“Muscle power declines by about 8 to 10% per year as we age.”
Dr. Andy Galpin (Professor of kinesiology and expert in muscle physiology and strength training) · Huberman Lab, September 2026 · watch the episode ↗︎ · stated with confidence
Research in humans shows that muscle strength declines by around 3 to 4% per year after the age of fifty. A loss of 8 to 10% per year is considerably higher than that and is not supported by the available evidence. The claim also refers to 'muscle power' (explosive power), which is a slightly different concept from muscle strength, but for this concept too there is no substantiation for such a high percentage. The direction is correct, the percentage is not.

Dr. Jared Rutter

Professor of biochemistry at the University of Utah and researcher at the Howard Hughes Medical Institute, specializing in mitochondria and metabolism

✓ Holds up
“Heart muscle cells undergo hardly any renewal throughout a person's lifetime.”
Dr. Jared Rutter (Professor of biochemistry at the University of Utah and researcher at the Howard Hughes Medical Institute, specializing in mitochondria and metabolism) · Huberman Lab, September 2026 · watch the episode ↗︎ · stated with confidence
Multiple human studies, including research using the so-called bomb pulse method to determine the age of heart muscle cells, show that these cells renew themselves only to a very limited extent throughout life. The rate of renewal declines from around 1% per year in youth to less than 1% per year in adulthood, and fewer than half of all heart muscle cells are replaced over an entire human lifetime. Review articles and modelling studies confirm that the rate of renewal in the adult heart is exceptionally low. The claim that heart muscle cells renew themselves "hardly at all" is well in line with what human research shows.

From the episodes, no speaker named

✗ Does not hold up
“Every pack of cigarettes a person smokes per day shortens their life expectancy by an estimated 14 years.”
Huberman Lab, November 2026 · watch the episode ↗︎ · stated with caution
It is well established that smoking significantly shortens life expectancy, but the figure of 14 years per pack per day does not appear in the research. Large-scale disease burden models do make clear that smoking costs many years of life, but a precise personal estimate like this cannot be given based on the available evidence. The figure sounds more definitive than the science warrants.
Partly
“Nicotine stimulates POMC neurons in the hypothalamus, thereby suppressing appetite.”
Huberman Lab, November 2026 · watch the episode ↗︎ · stated with confidence
Several animal studies (mice and rats, both in the lab and in brain slices) show that nicotine activates POMC neurons in the hypothalamus and that this contributes to reduced appetite. However, the picture is more complex than the claim suggests: nicotine simultaneously increases the activity of hunger-stimulating neurons as well, and exactly how the balance results in appetite suppression has not yet been fully clarified. Moreover, this mechanism has not been directly tested in humans, while the claim makes no distinction between animal and human research.
Too early
“Apigenin has an anxiety-reducing effect and helps reduce rumination before falling asleep.”
Huberman Lab, October 2026 · watch the episode ↗︎ · stated with confidence
Studies in rats and mice consistently show that apigenin has anxiety-reducing effects, although one animal study failed to demonstrate this effect in rats. Two systematic reviews of animal studies exclusively confirm the anxiolytic effect, and one review article notes that apigenin, via chamomile extract, can improve mood and anxiety in humans, but this concerns the extract as a whole and not isolated apigenin. As for the specific effect on rumination before falling asleep in humans, the evidence has not yet been tested in humans. The claim goes further than what the available research has demonstrated so far. → Does apigenin help you sleep better?
Partly
“1 to 3 grams of EPA per day from fish oil can help reduce depressive symptoms and improve mood.”
Huberman Lab, October 2026 · watch the episode ↗︎ · stated with caution
There is research suggesting that EPA may play a role in depressive symptoms, and the dosage mentioned in the claim is in line with the amounts used in studies. However, the evidence for omega-3 in depression is mixed: for postnatal depression, no demonstrable preventive effect has been found, and as a treatment the results are too inconsistent to support a recommendation. The claim presents the effect more assertively than the evidence allows, as a benefit has not been demonstrated for every form of depression, and the trial register shows that this area is still being actively researched.
Partly
“Tongkat ali (200 to 600 milligrams per day) increases free testosterone by lowering sex hormone-binding globulin.”
Huberman Lab, October 2026 · watch the episode ↗︎ · repeated in October 2026 · stated with confidence
Tongkat ali can increase testosterone; that is supported by the research. However, the specific mechanism via lowering of sex hormone-binding globulin and the precise dosage of 200 to 600 milligrams cannot be established on the basis of the available evidence. Moreover, a crucial caveat is that the EFSA found indications of DNA damage at precisely the stated dose of 200 milligrams per day, and the product is banned for sale in the EU. The claim presents tongkat ali as a viable option, while its safety profile undermines that.
✓ Holds up
“High doses of Fadogia agrestis can be toxic to cells in the testicles.”
Huberman Lab, October 2026 · watch the episode ↗︎ · stated with caution
Animal studies on Fadogia agrestis show damage to the testicles, and that picture is consistent with the claim that high doses can be toxic to cells in the testicles. The available evidence comes exclusively from animal research; this has not been tested in humans. Because Fadogia agrestis is also not authorised for sale in the EU, the risk for humans cannot yet be quantified, but the signals are serious enough to support the claim.
✗ Does not hold up
“The herb Fadogia agrestis (600 milligrams per day) can increase libido, sperm production and testosterone levels in many people.”
Huberman Lab, October 2026 · watch the episode ↗︎ · stated with caution
Fadogia agrestis has not been proven effective in humans for testosterone, libido or sperm production. The available animal studies actually show harmful effects on the kidneys, liver and testicles, which is an additional reason to exercise caution. Moreover, the product is not authorised for sale in the EU. The claim that it can increase these effects in "many people" is therefore unsubstantiated.
Partly
“Looking at morning sunlight raises the cortisol peak in the morning and ensures lower cortisol levels at night”
Huberman Lab, October 2026 · watch the episode ↗︎ · stated with confidence
That morning light influences cortisol regulation is biologically plausible: sunlight can raise cortisol and helps synchronise the biological clock, which indirectly also governs nocturnal cortisol levels. The available research shows, however, that the effects of sunlight on cortisol are less well quantified than those on, for example, melatonin or vitamin D. The claim is therefore more specific than what the evidence currently firmly establishes: that morning sunlight raises the morning cortisol peak and lowers nocturnal levels has not been demonstrated as two separate, measurable effects of that one habit.
✗ Does not hold up
“Melatonin supplements help with falling asleep, but often cause people to wake up in the middle of the night and have difficulty falling back asleep”
Huberman Lab, October 2026 · watch the episode ↗︎ · stated with confidence
That melatonin can help with falling asleep is supported by research, though the effect is modest. The second part of the claim, however, does not match what studies show: extended-release melatonin is specifically recommended for older adults precisely because of early waking, and nocturnal waking as a side effect of melatonin supplements is not described in the research. The claim reverses the picture: rather than melatonin making it harder to stay asleep, the evidence points more towards a certain benefit for that pattern of complaints.
Partly
“Magnesium threonate or magnesium bisglycinate shortens the time it takes to fall asleep and promotes deeper sleep”
Huberman Lab, October 2026 · watch the episode ↗︎ · stated with confidence
Magnesium can modestly help with sleep problems, but the studies are small, of low quality and partly contradict each other. This applies to magnesium glycinate and magnesium bisglycinate specifically as well: there are indications of a small benefit, but not of the definitive effects the claim suggests, such as a measurably shorter time to fall asleep and demonstrably deeper sleep. For magnesium threonate, trials in humans have been completed without published results, so whether this form adds anything cannot be determined on the basis of the available research.
✗ Does not hold up
“Taking 1 to 3 grams of EPA per day can improve metabolism, cardiovascular function, concentration and cognitive performance.”
Huberman Lab, October 2026 · watch the episode ↗︎ · stated with caution
The claim that EPA at this dosage improves metabolism, cardiovascular function, concentration and cognitive performance goes beyond what the research shows. For the heart and blood vessels, the opposite is actually true: higher doses of omega-3 supplements demonstrably increase the risk of atrial fibrillation, and there is no evidence that supplements prevent or resolve existing heart rhythm problems. For metabolism and cognition, the evidence for EPA supplements is still limited, and the best-supported ways to influence your metabolism are exercise, a protein-rich diet and strength training, not a specific supplement. The broad, positive wording of the claim is not supported by the research.
Newsletter

Stay in the loop

Every Thursday, the most important longevity research in your inbox, focused on what you follow.